Desmoid Tumor: Clinical Trials

14 trials for Desmoid Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 active not recruiting, 2 recruiting. 14 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 214Completed 10, Active not recruiting 2, Recruiting 2
Phase 14Completed 4
Phase 31Active not recruiting 1

Follow Desmoid Tumor: new trials by email Literature Review of Desmoid Tumor trials Research Report on Desmoid Tumor

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study in Adults With Desmoid Tumors
ES014 - Desmoid Tumor
Phase 2RecruitingElpiscience (Suzhou) Biopharma, Ltd.502026-04-242026-10-21
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
Nirogacestat oral tablet - Desmoid Tumor, Aggressive Fibromatosis
Phase 2Active not recruitingSpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany202025-08-082026-09-15
Study of Cryoablation and Nirogacestat for Desmoid Tumor
Nirogacestat, Cryoablation - Desmoid Tumor
Phase 2RecruitingNam Bui282023-08-152026-09-10
A Study of AL102 in Patients With Progressing Desmoid Tumors
AL102, Placebo - Desmoid, Desmoid Tumor
Phase 2 / Phase 3Active not recruitingImmunome, Inc.1982021-09-012026-06-08
A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
vactosertib/imatinib combination - Desmoid Tumor
Phase 1 / Phase 2CompletedHyo Song Kim242019-04-152024-05-13
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Nab-Rapamycin, Nivolumab - Ewing Sarcoma, PEComa
Phase 1 / Phase 2CompletedSarcoma Oncology Research Center, LLC342017-08-242025-02-17
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
Sirolimus - Desmoid Tumor
Phase 1 / Phase 2CompletedMaineHealth92014-02-012023-06-26
Study to Evaluate Imatinib in Desmoid Tumors
Imatinib - Aggressive Fibromatosis, Desmoid Tumor
Phase 2CompletedHeidelberg University392010-06-012017-05-03
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
sunitinib malate - Adult Malignant Fibrous Histiocytoma of Bone, Desmoid Tumor
Phase 2CompletedMemorial Sloan Kettering Cancer Center532007-04-012016-01-20
Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
imatinib mesylate - Desmoid Tumor
Phase 1 / Phase 2CompletedUNICANCER402004-09-012016-08-30
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
tamoxifen citrate, sulindac, laboratory biomarker analysis - Desmoid Tumor
Phase 2CompletedChildren's Oncology Group702004-02-012020-02-19
Radiation Therapy in Treating Patients With Aggressive Fibromatoses
radiation therapy - Desmoid Tumor
Phase 2CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC442001-11-012013-08-27
Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
methotrexate, vinblastine sulfate - Desmoid Tumor
Phase 2CompletedChildren's Oncology Group281997-08-012014-07-25
Toremifene in Treating Patients With Desmoid Tumors
toremifene, conventional surgery - Desmoid Tumor
Phase 2CompletedAdvocate Lutheran General Hospital721991-07-012013-07-10

Narrower conditions

Desmoid Tumors (14)  ·  Sarcoma (2)  ·  AIDS-related Kaposi sarcoma (1)  ·  Bone Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Squamous Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Chondrosarcoma (1)  ·  Chondrosarcoma, Extraskeletal Myxoid (1)  ·  Chordoma (1)  ·  Colorectal Neoplasms (1)  ·  Dermatofibrosarcoma (1)  ·  Desmoplastic Small Round Cell Tumor (1)

Broader conditions

Fibroma (14)  ·  Neoplasms (14)  ·  Neoplasms by Histologic Type (14)  ·  Neoplasms, Connective Tissue (14)  ·  Neoplasms, Connective and Soft Tissue (14)  ·  Neoplasms, Fibrous Tissue (14)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Bone Tissue (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neuroectodermal Tumors (2)  ·  Urogenital Diseases (2)

Interventions

Imatinib Mesylate (2)  ·  nirogacestat (2)  ·  Cryosurgery (1)  ·  Methotrexate (1)  ·  Nivolumab (1)  ·  Radiotherapy (1)  ·  Sirolimus (1)  ·  Sulindac (1)  ·  Sunitinib (1)  ·  Tamoxifen (1)  ·  Toremifene (1)  ·  Vinblastine (1)  ·  vactosertib (1)

Sponsors

Children's Oncology Group (2)  ·  Advocate Lutheran General Hospital (1)  ·  Elpiscience (Suzhou) Biopharma, Ltd. (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  Heidelberg University (1)  ·  Hyo Song Kim (1)  ·  Immunome, Inc. (1)  ·  MaineHealth (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Nam Bui (1)  ·  Sarcoma Oncology Research Center, LLC (1)  ·  SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany (1)  ·  UNICANCER (1)

Countries

United States (8)  ·  Germany (3)  ·  Australia (2)  ·  Belgium (2)  ·  France (2)  ·  Netherlands (2)  ·  Poland (2)  ·  South Korea (2)  ·  United Kingdom (2)  ·  Canada (1)  ·  China (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Spain (1)

Top investigators

Aaron R Weiss, DO (1)  ·  Bernd Kasper, PD Dr. med. (1)  ·  Brian L. Samuels, MD (1)  ·  Bruce Himelstein, MD (1)  ·  Erlinda M Gordon, MD (1)  ·  Jean-Yves Blay, MD, PhD (1)  ·  Mary L. Keohan, MD (1)  ·  Mrinal Gounder, MD (1)  ·  Nam Bui, M.D. (1)  ·  R. B. Keus, MD (1)  ·  Robert Maki, MD, PhD (1)  ·  Stephen Skapek, MD (1)  ·  Steve Skapek, MD (1)  ·  Thomas Schnabel, MD (1)

Results publications

PMID 17290057, PMID 19451429, PMID 20622000, PMID 24089446, PMID 26861905, PMID 28282612, PMID 31401903

NIH funding

P30CA008748 (1), U10CA098543 (1)